Zidovudine Plus Lamivudine in HTLV-I-associated Myelopathy: a Randomised Trial

Clinical trial NCT00272480 · COMPLETED

Trial details

NCT number: NCT00272480
Sponsor: Imperial College London
Status: COMPLETED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

HTLV-I-associated Myelopathy

Start date: 1999-11-08
Primary completion: 2002-07-30
Enrollment: 16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.